. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents, Phytogenic/administration & dosageClinical Trials, Phase II as TopicDrug ApprovalDrug CarriersHumansInternational AgenciesLiposomesMulticenter Studies as TopicPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyUnited StatesUnited States Food and Drug AdministrationVincristine/administration & dosage
Substances: See more » Antineoplastic Agents, PhytogenicDrug CarriersLiposomesVincristine
Year: 2012 PMID: 23061340
Source DB: PubMed Journal: Oncology (Williston Park) ISSN: 0890-9091 Impact factor: 2.990